This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Mirka Scarati: Innovator in Pharmaceutical Chemistry
Introduction
Mirka Scarati is a notable inventor based in Bigarello, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for various biological pathways.
Latest Patents
Scarati holds a patent for a compound known as 6-pyrimidin-isoindole derivative, which acts as an ERK1/2 inhibitor. This invention relates to the compound (2R)-2-(6-{5-chloro-2-[(oxan-4-yl)amino]pyrimidin-4-yl}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide. The patent details novel physical forms of the compound, a process for preparing it, synthetic intermediates for use in the process, and formulations containing the compound, along with its therapeutic applications.
Career Highlights
Mirka Scarati is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Scarati collaborates with esteemed colleagues, including Michael Reader and Nicola Elizabeth Wilsher, who contribute to his research endeavors and enhance the impact of his inventions.
Conclusion
Mirka Scarati's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new therapeutic agents. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes.